Firma Tentamus Group, Autor bei Presse-Blog

Renolab offers new testing services for biopesticides

26. März 2026 Firma Tentamus GroupBiotechnikbiological control, Biopesticides, biostimulants, contaminant quantification, Crop Protection, Five Batch Analysis, formulation testing, microbial strains, microbiological analysis, one-health, physico-chemical analysis, quality control, Regulatory Compliance, stability studies, sustainable agriculture

Biopesticides are among the most promising solutions to promote sustainable agriculture and reduce dependence on synthetic pesticides. Based on microorganisms, natural metabolites or substances of plant or animal origin, these products help protect crops while reducing environmental impact and food Mehr

GMW Bioscience Joins the Tentamus Group

5. März 202611. März 2026 Firma Tentamus GroupBiotechnikagribiotechnology, Agricultural Innovation, biological control, bioscience services, biostimulants, Contract Research Organization, cro, efficacy trials, field trials, GMW Bioscience, iberia, Regulatory Compliance, spain, Tentamus Group, valencia

GMW Bioscience, a Contract Research Organization (CRO) specializing in efficacy trials, biostimulants, and agribiotechnology services, has officially joined the Tentamus Group. As a trusted expert partner, GMW Bioscience supports its clients by conducting controlled and field trials covering efficacy, biostimulant, Mehr

Tentamus Group Appoints David Biacsi-Schoen as Head of Group IT and Director IT DACH

27. Februar 20265. März 2026 Firma Tentamus GroupFirmeninternbusiness alignment, Digitalization, Director IT DACH, governance, Head of Group IT, healthcare technology, information security, infrastructure, innovation, IT-Leadership, operational reliability, regional initiatives, Scalability

The Tentamus Group is pleased to announce that David Biacsi-Schoen will join the company effective March 1, 2026, assuming the dual roles of Head of Group IT and Director IT DACH. In his role as Director IT DACH, David will Mehr

Tentamus Group appoints Eva-Aster de Gier as Chief Operating Officer

27. Februar 20265. März 2026 Firma Tentamus GroupFirmeninternchief operating officer, continuous improvement, COO, Digitalization, efficiency, Executive Management, global teams, Group IT, Operational Excellence, procurement, quality, Scalability, sustainable growth

We’re pleased to announce that Eva-Aster de Gier will be appointed Chief Operating Officer (COO) effective March 1, 2026. Eva-Aster previously served as Tentamus’ Director of Operations, where she played a pivotal role in building our operational excellence network, modernizing Mehr

Laemmegroup Launches Major Expansion to Strengthen Laboratory Efficiency and Analytical Excellence

26. Februar 20264. März 2026 Firma Tentamus GroupForschung und Entwicklungcompliance, efficiency, ergonomics, excellence, expansion, Good Laboratory Practices, homogenization, integration, preparation, Prioritization, reliability, representativeness, ventilation, Workflow, workstations

Laemmegroup Laboratory has initiated a major operational expansion aimed at delivering an even more efficient, faster, and more reliable service to its clients. The entire operational workflow has been comprehensively redesigned, from sample receipt through to the issuance of analytical Mehr

Implementation of a bioanalytical control device for routine measurement of drug products at VelaLabs

12. Februar 202625. Februar 2026 Firma Tentamus GroupBiotechnikassay development, automated cartridge-based system, bioanalytical control, biological drug substances, capillary electrophoresis, capillary isoelectric focusing, CE-SDS, charge analysis, cIEF, IgG antibodies, Maurice device, method transfer (Sciex), monoclonal antibodies, SDS-PAGE, size analysis

Bioanalytical control of biological drug substances is performed at VelaLabs using new capillary electrophoresis sodium dodecyl sulphate (CE-SDS) and capillary isoelectric focusing (cIEF) technology for charge and size analysis. In 2025, VelaLabs (Vienna) performed multiple assay developments for monoclonal antibodies Mehr

Strong Communication as the Foundation of Reliable Life Science Consulting

2. Februar 20262. Februar 2026 Firma Tentamus GroupDienstleistungenalignment, Collaboration, communication structures, consulting quality, documentation, feedback culture, leadership, life sciences, reflection, regulatory requirements, reliability, team cohesion, team communication, Winter meeting, workshop

Professional excellence does not come from knowledge alone, but from people who share, question and develop their knowledge together. With this in mind, the teams at TentaConsult Pharma & Med GmbH gathered for their annual winter meeting on 22 and Mehr

Kommunikation als Voraussetzung verlässlicher Beratung!

2. Februar 20262. Februar 2026 Firma Tentamus GroupDienstleistungenAbstimmung, Beratungsqualität, dokumentation, Feedbackkultur, Führung, Kommunikationsstrukturen, life sciences, reflexion, regulatorische Anforderungen, teamkommunikation, Teamzusammenhalt, Verlässlichkeit, Wintermeeting, workshop, zusammenarbeit

Fachliche Exzellenz entsteht nicht allein durch Wissen, sondern durch Menschen, die ihr Wissen teilen, hinterfragen und gemeinsam weiterentwickeln. Vor diesem Hintergrund haben sich die Teams der TentaConsult Pharma & Med GmbH am 22. und 23. Januar 2026 zum jährlichen Wintermeeting Mehr

Tentamus UK Celebrates 10 Years of Scientific Excellence

22. Januar 202623. Januar 2026 Firma Tentamus GroupFirmeninternanalytical testing, beverage??, biocides, cosmetics testing, food, laboratory, laboratory testing, microbiology, network, quality systems, regulated industries, Regulatory Compliance, scientific excellence, strategic expansion, water testing

Tentamus UK celebrated its 10-year anniversary last year, marking a decade of delivering high-quality laboratory testing and scientific services to regulated industries across the United Kingdom. Founded with QTS Analytical – A Tentamus Company, Tentamus UK has since grown to Mehr

Techno Analisys joins the Tentamus Group in Italy

21. Januar 202623. Januar 2026 Firma Tentamus GroupBiotechnikaccreditation, acquisition, Biomedical, compliance, continuity, diagnostics, environmental, expansion, hse, innovation, integration, Mirandola, modena, quality, synergies

The Tentamus Group announces the entry of Techno Analisys into its network of specialized companies and laboratories in Italy, effective January 1, 2026. This transaction is part of the Group’s growth strategy aimed at strengthening its presence in the Italian Mehr

Autor: Firma Tentamus Group